Biogen (BIIB) PT Raised to $157 at Bernstein SocGen Group
Tweet Send to a Friend
Bernstein SocGen Group analyst William Pickering raised the price target on Biogen (NASDAQ: BIIB) to $157.00 (from $155.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
